Skip to content

Transmitted HIV drug resistance is persistent but is not harming treatment responses in the UK

START trial finds that early treatment improves outcomes for people with HIV

START trial finds that early treatment improves outcomes for people with HIV

High lifetime costs of treating HIV show importance of investing in prevention

Lower daily tenofovir dose of 150mg safe and effective in people with moderate renal impairment

Modern NNRTI regimens can be effective with 85% adherence

Five antiretroviral combinations associated with increased risk of a cardiovascular event

HIV infection and low CD4 count associated with hardening of arteries

People who don’t tell anyone else their HIV status have as good health outcomes as other people living with HIV

Treatment outcomes no better with single tablet regimens than individual tablets